NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹45 Cr | ₹46 Cr | ₹41 Cr | ₹20 Cr | ₹17 Cr |
What is the latest Capital Work in Progress ratio of NEULAND LABORATORIES ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹45 Cr |
| Mar2024 | ₹46 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹20 Cr |
| Mar2021 | ₹17 Cr |
How is Capital Work in Progress of NEULAND LABORATORIES Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹45 Cr | -2.92 | |
| Mar2024 | ₹46 Cr | 13.13 | |
| Mar2023 | ₹41 Cr | 98.30 | |
| Mar2022 | ₹20 Cr | 18.59 | |
| Mar2021 | ₹17 Cr | - | |
Compare Capital Work in Progress of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹23,145.2 Cr | 6.4% | 8.7% | 37.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,148.0 Cr | 2.6% | 1.2% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,009.0 Cr | 1.3% | -2.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,779.0 Cr | 1.5% | 0.7% | 37.1% | Stock Analytics | |
| CIPLA | ₹115,772.0 Cr | 6.1% | 2.4% | -5.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,616.0 Cr | 2.6% | -0.4% | -2.1% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 6.4% |
8.7% |
37.2% |
| SENSEX | -0.8% |
1.4% |
-6.8% |
You may also like the below Video Courses